This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What to Expect From These 4 Insurers This Earnings Season?
by Debasmita Chatterjee
Strong premiums, M&A activities and tech efficiencies are likely to have aided insurers' Q1 performance, despite pressure from low interest rates, inflationary headwinds and catastrophe-related losses.
MET to Report Q1 Earnings: What Do the Key Estimates Say?
by Zacks Equity Research
MET's first-quarter results are likely to benefit from higher group benefit revenues.
Unlocking Q1 Potential of MetLife (MET): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of MetLife (MET) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: American International Group (AIG) Q1 Earnings Expected to Decline
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife Joins SKYGEN to Revolutionize Dental Provider Experience
by Zacks Equity Research
MET partners with SKYGEN to simplify dental credentialing, enhance efficiency, and improve the provider experience.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife's New Latin America Unit Generates 4.5M Active Customers
by Zacks Equity Research
By leveraging technology and a startup-like agile model, MET aims to scale operations across Latin America.
Here's Why Investors Should Hold on to MetLife Stock Right Now
by Zacks Equity Research
MET benefits from higher premiums and cost-cutting initiatives.
Why Is MetLife (MET) Down 1.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights MetLife, American International, Prudential Financial, Radian and CNO Financial
by Zacks Equity Research
MetLife, American International, Prudential Financial, Radian and CNO Financial have been highlighted in this Industry Outlook article.
5 Multiline Insurers to Watch as Competition Rises, Pricing Moderates
by Tanuka De
Better pricing, product redesigns, technological advancement and improving inflation are expected to aid multiline insurers like MET, AIG, PRU, RDN and CNO.
MetLife Q4 Earnings Miss Estimates on Weak RIS & EMEA Unit
by Zacks Equity Research
Management expects a variable investment income of $1.7 billion for 2025.
Compared to Estimates, MetLife (MET) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Misses Q4 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -2.35% and 2.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPF
What's in Store for These Three Insurance Stocks in Q4 Earnings?
by Debasmita Chatterjee
Insurers like ALL, MET and AFL are likely to have witnessed premium growth in Q4. Lower interest rates are expected to have pressured life insurers' returns, while M&A, tech investments and catastrophe impacts shaped industry trends.
Will Rising Expenses Dampen MetLife's Q4 Earnings Growth?
by Zacks Equity Research
MET's fourth-quarter earnings are expected to have been affected by higher expenses and lower net investment income.
Stay Ahead of the Game With MetLife (MET) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Evaluate the expected performance of MetLife (MET) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Principal Financial (PFG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Principal Financial (PFG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Assurant Stock Trading at Discount to Industry at 2.07X: Time to Buy?
by Zacks Equity Research
AIZ stock is poised to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses and effective capital deployment.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
MetLife Expands Asset Management With $6B Acquisition From Mesirow
by Zacks Equity Research
MetLife Investment Management boosts its portfolio with a $6B acquisition from Mesirow, adding high-yield strategies, small-cap equity expertise and 20 seasoned professionals to fuel growth.